June 2026 in “Homo Politicus (Academy of Humanities and Economics in Lodz)” The effectiveness of ingredients in anti-hair loss products varies, and clinical trials are crucial to determine their success.
An automated system can accurately classify hair disorders using image analysis.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common, with different types affecting people due to genetics, stress, or autoimmune issues.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common and varies by type, with androgenetic alopecia being the most prevalent.
Post-earthquake, skin issues like dermatitis and infections were common due to trauma, disinfectants, and stress.
February 2026 in “International Journal of Science and Research (IJSR)” Androgenetic alopecia is the most common hair disorder, affecting more males, while telogen effluvium is more common in females, with stress and nutrition as key factors.
January 2026 in “Annals of Dermatology” Many dermatology patients experienced anxiety, depression, PTSD, and skin issues after the February 6, 2023 earthquakes, highlighting the need for combined skin and mental health care.
December 2025 in “Medicine - Programa de Formación Médica Continuada Acreditado” Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.
November 2025 in “Skin Appendage Disorders” Ayurvedic treatments may help improve hair health and growth.
Hair and nail disorders can harm self-esteem, but early treatment helps.
November 2025 in “Advanced Science” A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.
October 2025 in “EMJ Dermatology” GLP-1RA therapy may increase the risk of hair loss.
September 2025 in “Cosmoderma” Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.
August 2025 in “Aesthetic Plastic Surgery” Collaboration and innovation are key to developing effective, safe hair loss treatments.
June 2025 in “British Journal of Dermatology” Trichoscopy is highly effective for diagnosing scalp disorders and should be used more in dermatology.
June 2025 in “British Journal of Dermatology” Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.
Non-drug treatments like saw palmetto, horsetail, pumpkin seed oil, curcumin, and addressing nutritional deficiencies may help female hair loss.
June 2025 in “Pediatric Annals” Early detection and treatment of hair loss in teens is crucial to prevent permanent loss and boost self-esteem.
April 2025 in “International Journal of Research in Dermatology” Thyroid disorders are linked to skin issues and autoimmune skin diseases.
April 2025 in “Clinical Dermatology Review” Trichoscopy is effective for diagnosing hair and scalp disorders without invasive biopsies.
January 2025 in “Journal of the European Academy of Dermatology and Venereology” Newer GLP-1 drugs like semaglutide may cause hair loss.
January 2025 in “Skin Appendage Disorders” Herbal remedies may help hair growth, but more research is needed.
January 2025 in “Universitätsbibliothek Stuttgart” Multidisciplinary collaboration is crucial for advancing hair loss treatments and regrowth products.
November 2024 in “GSC Biological and Pharmaceutical Sciences” Phytochemicals from plants can improve hair growth, strength, and scalp health.
November 2024 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” The method increased hair volume, thickened strands, and reduced hair loss.
September 2024 in “PubMed” Hair loss can be treated based on its type and cause, improving quality of life.
April 2024 in “Brazilian Journal of Health Review” COVID-19 may trigger hair loss in some people.
April 2024 in “REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS” COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.
April 2024 in “Clinical dermatology review (Print)” Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
AI can predict hair loss patterns to improve care and treatment.